The MS Australia Clinical Trials Network was established to facilitate the advancement of improved treatments for MS through clinical trials in Australia. It serves as the primary resource for individuals interested in participating in or conducting trials and research studies, as well as for updates on MS clinical research and trial activity.
The goal of the MS Australia Clinical Trials Network is to streamline the process of conducting MS clinical trials in Australia, making it a straightforward location for such trials, and to enhance accessibility to information and trial opportunities for individuals with MS and other demyelinating diseases.
The MS Australia Clinical Trials Network does not aim to replace direct interaction between trial sponsors and neurologists or individual trial sites. Instead, its purpose is to facilitate connections and enhance the exchange of information.
Services and Resources
Connecting people with MS and other demyelinating diseases to MS clinical trials sites
Access to expert review and advice on the optimal approach for the establishment of a clinical trial in Australia
Access to leading neurologists and other health professionals around Australia and NZ
Rapid access to potential trial site feasibility information
Latest information on clinical research and trial activity in Australia and around the world
Dissemination of information amongst the MS neurology and scientific community
A single conduit for garnering expressions of interest from potential trial sites for new trials
Advocacy activity regarding clinical trials and patient access to efficacious treatments
Governance and Expertise
MS Clinical Trials Network is coordinated by MS Australia. The Network’s Executive Committee consists of MS neurologist representatives from Australia and New Zealand, supported by a Scientific Review Committee.
Executive Committee
PROFESSOR JEANNETTE LECHNER-SCOTT
Chair
Staff Specialist, Dept Neurology, John Hunter Hospital; Conjoint Senior Lecturer, University Newcastle (NSW)
ASSOCIATE PROFESSOR MARK SLEE
BAppSc, BMBS, FRACP, PhD
Senior Consultant Neurologist; Lecturer in Medicine, Flinders University and Medical Centre (SA)
ASSOCIATE PROFESSOR ROB HEARD
BAppSc, BMBS, FRACP, PhD
Clinical Associate Professor, Medicine, Westmead Clinical School, Westmead Hospital (NSW)
ASSOCIATE PROFESSOR MICHAEL BARNETT
MBBS FRACP PhD
Senior Lecturer in Neurology, Medicine, Central Clinical School, Brain and Mind Research Institute, University of Sydney (NSW)
PROFESSOR SIMON BROADLEY
BSc (Hons), MB, ChB, MRCP(UK), PhD, FRACP
Professor of Neurology, Dean of Medicine, School of Medicine, Griffith University (QLD)
PROFESSOR BRUCE TAYLOR
Bmed sci, MB.BS., MD, FRACP
Principal Research Fellow, Menzies Research Institute; Staff Specialist, Royal Hobart Hospital (TAS)
PROFESSOR HELMUT BUTZKUEVEN
Principal Research Fellow, Florey Neuroscience Institutes and Centre for Neuroscience, University of Melbourne; MS Neurologist, Royal Melbourne Hospital; Director of MS services, Box Hill Hospital (VIC)
PROFESSOR ALLAN KERMODE
Chair
Consultant Neurologist, Sir Charles Gairdner Hospital; Centre for Neuromuscular and Neurological Diseases, Australian Neuromuscular Research Institute, Perth (WA)
PROFESSOR BILL CARROLL
MSSB MD FRACP FRCP (E)
Consultant Neurologist, Sir Charles Gairdner Hospital; Centre for Neuromuscular and Neurological Disorders, Australian Neuromuscular Research Institute, Perth (WA)
DR ERNIE WILLOUGHBY
Neurologist, Auckland District Health Board; Senior Lecturer, Department of Medicine, University of Auckland, New Zealand
